These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12654507)

  • 1. Elevated D3 dopamine receptor mRNA in dopaminergic and dopaminoceptive regions of the rat brain in response to morphine.
    Spangler R; Goddard NL; Avena NM; Hoebel BG; Leibowitz SF
    Brain Res Mol Brain Res; 2003 Mar; 111(1-2):74-83. PubMed ID: 12654507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.
    Han M; Huang XF; Deng C
    Int J Neuropsychopharmacol; 2009 Aug; 12(7):941-52. PubMed ID: 19203411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced gene expression for dopamine biosynthesis and transport in midbrain neurons of adult male rats exposed prenatally to ethanol.
    Szot P; White SS; Veith RC; Rasmussen DD
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1643-9. PubMed ID: 10549997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat.
    Shepard JD; Chuang DT; Shaham Y; Morales M
    Psychopharmacology (Berl); 2006 May; 185(4):505-13. PubMed ID: 16555063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular anatomy of the development of the human substantia nigra.
    Aubert I; Brana C; Pellevoisin C; Giros B; Caille I; Carles D; Vital C; Bloch B
    J Comp Neurol; 1997 Mar; 379(1):72-87. PubMed ID: 9057113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice.
    Le Foll B; Diaz J; Sokoloff P
    Life Sci; 2005 Jan; 76(11):1281-96. PubMed ID: 15642598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinatal delta9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats.
    García-Gil L; Ramos JA; Rubino T; Parolaro D; Fernández-Ruiz JJ
    Neurotoxicol Teratol; 1998; 20(5):549-53. PubMed ID: 9761594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of D3 receptors in the zitter mutant rat is not reversed by L-dopa treatment.
    Joyce JN; Der TC; Renish L; Osredkar T; Hagner D; Reploge M; Sakakibara S; Ueda S
    Exp Neurol; 2004 May; 187(1):178-89. PubMed ID: 15081599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midbrain muscarinic receptors modulate morphine-induced accumbal and striatal dopamine efflux in the rat.
    Miller AD; Forster GL; Yeomans JS; Blaha CD
    Neuroscience; 2005; 136(2):531-8. PubMed ID: 16216430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiate-like effects of sugar on gene expression in reward areas of the rat brain.
    Spangler R; Wittkowski KM; Goddard NL; Avena NM; Hoebel BG; Leibowitz SF
    Brain Res Mol Brain Res; 2004 May; 124(2):134-42. PubMed ID: 15135221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter.
    Fauchey V; Jaber M; Caron MG; Bloch B; Le Moine C
    Eur J Neurosci; 2000 Jan; 12(1):19-26. PubMed ID: 10651856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active versus passive cocaine administration: differences in the neuroadaptive changes in the brain dopaminergic system.
    Stefański R; Ziółkowska B; Kuśmider M; Mierzejewski P; Wyszogrodzka E; Kołomańska P; Dziedzicka-Wasylewska M; Przewłocki R; Kostowski W
    Brain Res; 2007 Jul; 1157():1-10. PubMed ID: 17544385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualization of dopamine D1, D2 and D3 receptor mRNAs in human and rat brain.
    Mengod G; Villaró MT; Landwehrmeyer GB; Martinez-Mir MI; Niznik HB; Sunahara RK; Seeman P; O'Dowd BF; Probst A; Palacios JM
    Neurochem Int; 1992 Mar; 20 Suppl():33S-43S. PubMed ID: 1365451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia.
    Galter D; Buervenich S; Carmine A; Anvret M; Olson L
    Neurobiol Dis; 2003 Dec; 14(3):637-47. PubMed ID: 14678778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin induces tyrosine hydroxylase mRNA expression in the ventral mesencephalon but not in the hypothalamus.
    Venero JL; Absi el-H; Cano J; Machado A
    J Pineal Res; 2002 Jan; 32(1):6-14. PubMed ID: 11841594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental area.
    Lessard A; Pickel VM
    Neuroscience; 2005; 135(4):1309-23. PubMed ID: 16165296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.
    Haber SN; Ryoo H; Cox C; Lu W
    J Comp Neurol; 1995 Nov; 362(3):400-10. PubMed ID: 8576447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
    Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
    Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rats bred for enhanced apomorphine susceptibility have elevated tyrosine hydroxylase mRNA and dopamine D2-receptor binding sites in nigrostriatal and tuberoinfundibular dopamine systems.
    Rots NY; Cools AR; Bérod A; Voorn P; Rostène W; de Kloet ER
    Brain Res; 1996 Feb; 710(1-2):189-96. PubMed ID: 8963658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.